EP1128832A4 - Composes, compositions et procedes pour traiter des infections virales et les maladies qui y sont liees - Google Patents
Composes, compositions et procedes pour traiter des infections virales et les maladies qui y sont lieesInfo
- Publication number
- EP1128832A4 EP1128832A4 EP99942288A EP99942288A EP1128832A4 EP 1128832 A4 EP1128832 A4 EP 1128832A4 EP 99942288 A EP99942288 A EP 99942288A EP 99942288 A EP99942288 A EP 99942288A EP 1128832 A4 EP1128832 A4 EP 1128832A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- treating
- compounds
- methods
- viral infections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9747698P | 1998-08-21 | 1998-08-21 | |
US97476P | 1998-08-21 | ||
US11321298P | 1998-12-22 | 1998-12-22 | |
US113212P | 1998-12-22 | ||
US11932899P | 1999-02-09 | 1999-02-09 | |
US119328P | 1999-02-09 | ||
US13558699P | 1999-05-24 | 1999-05-24 | |
US13558599P | 1999-05-24 | 1999-05-24 | |
US135586P | 1999-05-24 | ||
US135585P | 1999-05-24 | ||
PCT/US1999/018785 WO2000010573A1 (fr) | 1998-08-21 | 1999-08-19 | Composes, compositions et procedes pour traiter des infections virales et les maladies qui y sont liees |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1128832A1 EP1128832A1 (fr) | 2001-09-05 |
EP1128832A4 true EP1128832A4 (fr) | 2003-03-05 |
Family
ID=27536838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99942288A Withdrawn EP1128832A4 (fr) | 1998-08-21 | 1999-08-19 | Composes, compositions et procedes pour traiter des infections virales et les maladies qui y sont liees |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1128832A4 (fr) |
JP (1) | JP2002523371A (fr) |
KR (1) | KR20010099623A (fr) |
CN (1) | CN1325309A (fr) |
AU (1) | AU743411B2 (fr) |
BR (1) | BR9913157A (fr) |
CA (1) | CA2341970A1 (fr) |
ID (1) | ID27787A (fr) |
IL (1) | IL141456A0 (fr) |
WO (1) | WO2000010573A1 (fr) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0011441A (pt) * | 1999-06-10 | 2002-07-16 | Warner Lambert Co | Derivados de rodanina para uso em um método de inibição da agregação da proteìna amilóide e formação de imagens de depósitos amilóides |
EA200200311A1 (ru) | 1999-08-31 | 2002-08-29 | Максиа Фармасьютикалз, Инк. | Бензилиден-тиазолидиндионы и аналоги и их применение для лечения диабета |
US6727267B2 (en) | 2000-04-05 | 2004-04-27 | Tularik Inc. | NS5B HVC polymerase inhibitors |
US6448281B1 (en) | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
IL154993A0 (en) * | 2000-09-29 | 2003-10-31 | Neurogen Corp | High affinity small molecule c5a receptor modulators |
PL373912A1 (en) | 2001-03-07 | 2005-09-19 | Incyte San Diego, Inc. | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
US7265139B2 (en) | 2001-03-08 | 2007-09-04 | Incyte San Diego Inc. | RXR activating molecules |
GB2376944A (en) * | 2001-05-18 | 2002-12-31 | Pantherix Ltd | Polycyclic heterocyclic compounds and their therapeutic use |
WO2003007945A1 (fr) | 2001-07-20 | 2003-01-30 | Boehringer Ingelheim (Canada) Ltd. | Inhibiteurs de polymerase virale |
EP2335700A1 (fr) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Inhibiteurs de la polymerase du virus hepatitis C avec une structure heterobicylic |
US20030134853A1 (en) | 2001-09-26 | 2003-07-17 | Priestley Eldon Scott | Compounds useful for treating hepatitis C virus |
WO2003043998A1 (fr) * | 2001-11-15 | 2003-05-30 | Incyte San Diego Incorporated | Heterocycles n-substitues pour le traitement de l'hypercholesterolemie, de la dyslipidemie et autres troubles du metabolisme, du cancer et de pathologies diverses |
US7102000B2 (en) | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
US7196108B2 (en) | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
GB2387172A (en) * | 2002-03-28 | 2003-10-08 | Pantherix Ltd | [(Aryl-/arylthio-)aryl]methylene substituted azole & azine derivatives and their therapeutic use as antibacterials |
WO2003097621A1 (fr) * | 2002-05-17 | 2003-11-27 | Qlt Inc. | Procedes d'utilisation de derives de thiazolidinedithione |
MY140680A (en) | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
PL211889B1 (pl) | 2002-05-20 | 2012-07-31 | Bristol Myers Squibb Co | Pochodna heterocyklosulfonamidowa, kompozycja ją zawierająca oraz ich zastosowanie |
JP4271148B2 (ja) | 2002-05-20 | 2009-06-03 | ブリストル−マイヤーズ スクイブ カンパニー | 置換シクロアルキルp1’c型肝炎ウイルスインヒビター |
EP1506172B1 (fr) | 2002-05-20 | 2011-03-30 | Bristol-Myers Squibb Company | Inhibiteurs du virus de l'hepatite c |
BR0305426A (pt) | 2002-07-01 | 2004-08-24 | Upjohn Co | Compostos inibidores de ns5b polimerase de hcv, bem como composição farmacêutica compreendendo os mesmos |
BR0305259A (pt) | 2002-07-01 | 2004-10-05 | Upjohn Co | Inibidores de hcv ns5b polimerase |
FR2845000B1 (fr) | 2002-09-27 | 2005-05-27 | Oreal | Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute |
US7235573B2 (en) | 2002-09-30 | 2007-06-26 | The Regents Of The University Of California | Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors |
KR20050061501A (ko) * | 2002-09-30 | 2005-06-22 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 낭종 섬유증 트랜스막 전도도 조절기 단백질 억제제 및이의 용도 |
EP1597255A1 (fr) * | 2002-11-13 | 2005-11-23 | Rigel Pharmaceuticals, Inc. | Derives de rhodanine et compositions pharmaceutiques les contenant |
ATE422895T1 (de) | 2003-04-16 | 2009-03-15 | Bristol Myers Squibb Co | Makrocyclische isochinolinpeptidinhibitoren des hepatitis-c-virus |
EP1651226B1 (fr) * | 2003-07-11 | 2010-02-24 | Proteologics, Inc. | Inhibiteurs de l'ubiquitine ligase et methodes associees |
FR2858324A1 (fr) * | 2003-07-30 | 2005-02-04 | Centre Nat Rech Scient | Nouveaux composes antibiotiques, compositions pharmaceutiques les contenant et leurs utilisations |
US7112601B2 (en) | 2003-09-11 | 2006-09-26 | Bristol-Myers Squibb Company | Cycloalkyl heterocycles for treating hepatitis C virus |
WO2005041951A2 (fr) * | 2003-10-28 | 2005-05-12 | Rigel Pharmaceuticals, Inc. | Compositions de rhodanine utilisables comme agents antiviraux |
US7026339B2 (en) | 2003-11-07 | 2006-04-11 | Fan Yang | Inhibitors of HCV NS5B polymerase |
US7132504B2 (en) | 2003-11-12 | 2006-11-07 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US7135462B2 (en) | 2003-11-20 | 2006-11-14 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US7309708B2 (en) | 2003-11-20 | 2007-12-18 | Birstol-Myers Squibb Company | Hepatitis C virus inhibitors |
EA013207B1 (ru) | 2004-02-20 | 2010-04-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Ингибиторы вирусной полимеразы |
DE602005013922D1 (de) | 2004-02-24 | 2009-05-28 | Japan Tobacco Inc | Kondensierte heterotetracyclische verbindungen und deren verwendung als hcv-polymerase-inhibitor |
US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
MX2007013415A (es) | 2005-05-04 | 2008-01-15 | Hoffmann La Roche | Compuestos antivirales heterociclicos. |
EP1896033A4 (fr) * | 2005-06-15 | 2010-12-22 | New York Blood Ct Inc | Compositions antivirales comprenant des phenyl-furanes heterocycliques substitues et composes associes |
US8017612B2 (en) | 2006-04-18 | 2011-09-13 | Japan Tobacco Inc. | Piperazine compound and use thereof as a HCV polymerase inhibitor |
EP2019830A4 (fr) * | 2006-05-04 | 2011-01-19 | Inst Hepatitis & Virus Res | Inhibiteurs de la sécrétion d'antigènes du virus de l'hépatite b destinés au traitement d'un virus de l'hépatite chronique |
NZ575889A (en) | 2006-10-10 | 2011-09-30 | Medivir Ab | Hcv nucleoside inhibitor |
WO2008082537A2 (fr) | 2006-12-19 | 2008-07-10 | The General Hospital Corporation | Composés pour moduler l'intégrine cd11b/cd18 |
MX2009013827A (es) | 2007-06-29 | 2010-03-01 | Gilead Sciences Inc | Compuestos antivirales. |
TW200914013A (en) | 2007-06-29 | 2009-04-01 | Gilead Sciences Inc | Antiviral compounds |
EP2217573A4 (fr) | 2007-11-01 | 2011-08-31 | Uab Research Foundation | Traitement et prévention d'infections virales |
AU2008350907A1 (en) | 2007-12-11 | 2009-08-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
US7947717B2 (en) | 2008-07-18 | 2011-05-24 | Burnham Institute For Medical Research | Inhibitors of lethal factor protease |
BRPI0922366B8 (pt) | 2008-12-03 | 2021-05-25 | Presidio Pharmaceuticals Inc | composto, composição farmacêutica e uso de um composto |
CN102300462B (zh) | 2008-12-03 | 2015-01-28 | 普雷西迪奥制药公司 | Hcv ns5a的抑制剂 |
PE20120773A1 (es) | 2009-03-27 | 2012-07-19 | Presidio Pharmaceuticals Inc | Anillos triciclicos fusionados sustituidos como inhibidores del virus de hepatitis c |
CA2780044A1 (fr) | 2009-11-14 | 2011-05-19 | F. Hoffmann-La Roche Ag | Marqueurs biologiques destines a predire une reaction rapide au traitement du virus de l'hepatite c (hcv) |
EP2507636A1 (fr) | 2009-12-02 | 2012-10-10 | F. Hoffmann-La Roche AG | Biomarqueurs pour prédire une réponse soutenue à un traitement du vhc |
US20130065897A1 (en) * | 2009-12-23 | 2013-03-14 | Peter Maccallum Cancer Institute | Compounds, preparation and uses thereof |
US8877707B2 (en) | 2010-05-24 | 2014-11-04 | Presidio Pharmaceuticals, Inc. | Inhibitors of HCV NS5A |
KR101159000B1 (ko) | 2010-06-18 | 2012-06-21 | (주) 에빅스젠 | 신규한 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 aids 예방 또는 치료용 약학 조성물 |
US9023876B2 (en) | 2010-07-08 | 2015-05-05 | Adhaere Pharmaceuticals, Inc. | Compounds and methods for regulating integrins |
US9255088B2 (en) | 2010-08-11 | 2016-02-09 | The Regents Of The University Of California | Premature-termination-codons readthrough compounds |
WO2012123298A1 (fr) | 2011-03-11 | 2012-09-20 | F. Hoffmann-La Roche Ag | Composés antiviraux |
US20120328565A1 (en) | 2011-06-24 | 2012-12-27 | Brinkman John A | Antiviral compounds |
KR101621181B1 (ko) | 2011-10-10 | 2016-05-13 | 에프. 호프만-라 로슈 아게 | 항바이러스성 화합물 |
CA2855574A1 (fr) | 2011-12-16 | 2013-06-20 | F. Hoffmann-La Roche Ag | Inhibiteurs de ns5a de vhc |
CN108409820A (zh) | 2011-12-20 | 2018-08-17 | 里博科学有限责任公司 | 作为hcv rna复制抑制剂的4′-叠氮基,3′-氟取代的核苷衍生物 |
AU2012357940B2 (en) | 2011-12-20 | 2017-02-16 | Riboscience Llc | 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication |
JP6092261B2 (ja) | 2012-02-24 | 2017-03-08 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 抗ウイルス化合物 |
EP2828249B1 (fr) | 2012-03-23 | 2018-10-10 | The Regents of The University of California | Composés de translecture de codons de terminaison prématurés |
ES2766751T3 (es) | 2012-04-20 | 2020-06-15 | Gb006 Inc | Composiciones para la regulación de integrinas |
US20140010783A1 (en) | 2012-07-06 | 2014-01-09 | Hoffmann-La Roche Inc. | Antiviral compounds |
MX2015009176A (es) | 2013-01-23 | 2015-11-09 | Hoffmann La Roche | Derivados de triazola antivirales. |
MX2015011193A (es) | 2013-03-05 | 2015-11-13 | Hoffmann La Roche | Compuestos antivirales. |
RU2534613C2 (ru) | 2013-03-22 | 2014-11-27 | Александр Васильевич Иващенко | Алкил 2-{ [(2r,3s,5r)-5-(4-амино-2-оксо-2н-пиримидин-1-ил)- -гидрокси-тетрагидро-фуран-2-илметокси]-фенокси-фосфориламино} -пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения |
CN105307662B (zh) | 2013-05-16 | 2019-06-04 | 里博科学有限责任公司 | 4’-氟-2’-甲基取代的核苷衍生物 |
US20180200280A1 (en) | 2013-05-16 | 2018-07-19 | Riboscience Llc | 4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication |
AU2014272055A1 (en) | 2013-05-16 | 2015-12-24 | Riboscience Llc | 4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives |
EP3684374A4 (fr) | 2017-09-21 | 2021-06-16 | Riboscience LLC | Dérivés nucléosidiques à substitution 4'-fluoro-2'-méthyle utilisés comme inhibiteurs de la réplication de l'arn du vhc |
KR101893988B1 (ko) | 2018-05-16 | 2018-08-31 | (주)에빅스젠 | 로다닌 유도체를 함유하는 aids 예방 또는 치료용 약학 조성물 |
WO2023161427A1 (fr) | 2022-02-24 | 2023-08-31 | Eisbach Bio Gmbh | Polythérapie virale |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993021934A1 (fr) * | 1992-05-01 | 1993-11-11 | Commonwealth Scientific And Industrial Research Organisation | Heteropolytungstates utilises dans le traitement des infections a flavivirus |
WO1998020013A1 (fr) * | 1996-11-07 | 1998-05-14 | Andreas Johannes Kesel | Nouveaux produits de condensation de knoevenagel, leur procede de production et leur utilisation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909467A (en) * | 1958-07-09 | 1959-10-20 | Us Vitamin Pharm Corp | 3-(d-alpha-methylphenethyl)-5-methyl-1, 3-oxazolidine-2, 4-dione |
US3888984A (en) * | 1972-03-13 | 1975-06-10 | Lilly Industries Ltd | Oxazole and imidazole derivatives as antifungal agents |
AU6610081A (en) * | 1980-01-24 | 1981-07-30 | Senju Pharmaceutical Co., Ltd. | Thiazolidine derivatives |
US4367234A (en) * | 1980-07-28 | 1983-01-04 | Pfizer Inc. | Hypoglycemic 5-substituted oxazolidine-2,4-diones |
CA2153553A1 (fr) * | 1994-07-13 | 1996-01-14 | Hidekazu Suzuki | Emulsion stable de lipides |
US5834466A (en) * | 1994-12-22 | 1998-11-10 | The Regents Of The University Of California | Method for protecting of heart by limiting metabolic and ionic abnormalities developed during ischemia, following ischemia or resulting from ischemia |
-
1999
- 1999-08-19 EP EP99942288A patent/EP1128832A4/fr not_active Withdrawn
- 1999-08-19 CA CA002341970A patent/CA2341970A1/fr not_active Abandoned
- 1999-08-19 BR BR9913157-9A patent/BR9913157A/pt not_active Application Discontinuation
- 1999-08-19 CN CN99812282A patent/CN1325309A/zh active Pending
- 1999-08-19 ID IDW20010428A patent/ID27787A/id unknown
- 1999-08-19 WO PCT/US1999/018785 patent/WO2000010573A1/fr not_active Application Discontinuation
- 1999-08-19 JP JP2000565894A patent/JP2002523371A/ja active Pending
- 1999-08-19 AU AU55702/99A patent/AU743411B2/en not_active Ceased
- 1999-08-19 IL IL14145699A patent/IL141456A0/xx unknown
- 1999-08-19 KR KR1020017002117A patent/KR20010099623A/ko not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993021934A1 (fr) * | 1992-05-01 | 1993-11-11 | Commonwealth Scientific And Industrial Research Organisation | Heteropolytungstates utilises dans le traitement des infections a flavivirus |
WO1998020013A1 (fr) * | 1996-11-07 | 1998-05-14 | Andreas Johannes Kesel | Nouveaux produits de condensation de knoevenagel, leur procede de production et leur utilisation |
Non-Patent Citations (1)
Title |
---|
See also references of WO0010573A1 * |
Also Published As
Publication number | Publication date |
---|---|
ID27787A (id) | 2001-04-26 |
JP2002523371A (ja) | 2002-07-30 |
CN1325309A (zh) | 2001-12-05 |
IL141456A0 (en) | 2002-03-10 |
KR20010099623A (ko) | 2001-11-09 |
BR9913157A (pt) | 2001-05-15 |
EP1128832A1 (fr) | 2001-09-05 |
AU743411B2 (en) | 2002-01-24 |
CA2341970A1 (fr) | 2000-03-02 |
AU5570299A (en) | 2000-03-14 |
WO2000010573A1 (fr) | 2000-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1128832A4 (fr) | Composes, compositions et procedes pour traiter des infections virales et les maladies qui y sont liees | |
EP1109580A4 (fr) | Methodes de traitement ou de prevention des infections virales et des maladies associees | |
EP1115286A4 (fr) | Procedes de traitement ou de prevention d'infections virales et de maladies associees | |
AU1099000A (en) | Novel compounds and compositions for treating hepatitis c infections | |
HK1023371A1 (en) | Compositions and methods for treating viral infections | |
PL344223A1 (en) | Compositions for the treatment of hiv and other viral infections | |
AP2000002010A0 (en) | Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof | |
EP1109548A4 (fr) | Utilisation de procedes et de compositions a base de tocotrienols pour traiter et prevenir les maladies osseuses | |
EP1051169A4 (fr) | Composes, compositions et methodes de traitement ou de prevention d'infections pneumovirales et de maladies associees | |
EP0920419A4 (fr) | Composes, compositions et procedes de traitement de la grippe | |
AU7165498A (en) | Methods for treating viral infections | |
AU2002324753A1 (en) | Composition and method for treating viral infection | |
ZA200203435B (en) | Method and compositions for treating pulmonary diseases. | |
EP1135137A4 (fr) | Compositions polymeres servant a traiter des infections virales | |
IL133760A0 (en) | Composition for the treatment of dandruff | |
ZA977874B (en) | Pharmaceutical compositions for treating viral diseases | |
AU2003237088A8 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
HUP0102772A3 (en) | Novel compounds derived from alpha-d-xylose, preparation method and therapeutic use | |
AU6798000A (en) | Compounds, compositions and methods for treating influenza | |
AU3698199A (en) | Radioimmuno-pharmacon for treating the hiv-1 infection | |
ZA200004856B (en) | Treatment of panic attacks. | |
HUP9900123A3 (en) | 1-isothiazolidinone derivatives of azetidine-2-one, processes for the preparation thereof and use thereof | |
GB0117819D0 (en) | Pharmaceutical preparation for treating viral infections | |
EP1027352A4 (fr) | Composes antibacteriens de la classe des carbapenemes, compositions et procedes de traitement | |
EP1032384A4 (fr) | Composes antibacteriens, compositions et procedes de traitement aux carbapenemes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010315 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030122 |
|
17Q | First examination report despatched |
Effective date: 20040226 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040908 |